AbbVie faces the biggest challenge yet to its best-selling medicine, Humira, as an unlikely Icelandic drugmaker launches a legal fight over 'outrageous' patents

AbbVie faces the biggest challenge yet to its best-selling medicine, Humira, as an unlikely Icelandic drugmaker launches a legal fight over ‘outrageous’ patents

Summary List PlacementPressure is rising on AbbVie as the $203 billion pharmaceutical company faces congressional scrutiny and a new legal battle over the core of its business.
The Icelandic generic-drug specialist Alvotech launched a legal battle this week a…

Read More…

You May Also Like